Low molecular weight heparin oral - EmisphereAlternative Names: LMWH oral
Latest Information Update: 09 May 2011
At a glance
- Originator Emisphere Technologies
- Class Low molecular weight heparins
- Mechanism of Action Thrombin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 25 Feb 2004 This compound is still in active development
- 18 Jul 2003 Phase-I clinical trials in Thrombosis in USA (PO)
- 01 Aug 2002 This compound is still in active development